Valuation Gedeon Richter LUXEMBOURG S.E.

Stocks

CHWGR

US3684672054

Pharmaceuticals

End-of-day quote LUXEMBOURG S.E. Other stock markets 27/07/2026			5-day change	1st Jan Change
37.20 ^USD	+1.09%		-1.59%	+23.18%

29/06	Gedeon Richter plc announces Resignation of Péter Cserháti as Member of the Board of Directors, with Effect from 1 July 2026	CI
16/06	AI in Hungary could unlock productivity gains of EUR15 billion, McKinsey says	RE

Company Valuation: Gedeon Richter

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	16,19,625	15,42,290	16,27,029	18,93,161	17,99,226	21,41,234	-	-
Change	-	-4.77%	5.49%	16.36%	-4.96%	19.01%	-	-
Enterprise Value (EV) ¹	15,59,769	13,95,557	15,46,536	17,82,343	15,88,618	18,26,644	17,19,843	16,01,229
Change	-	-10.53%	10.82%	15.25%	-10.87%	14.98%	-5.85%	-6.9%
P/E	11.6x	9.94x	10.2x	7.96x	7.76x	8.2x	7.52x	6.87x
PBR	1.78x	1.47x	1.44x	1.49x	1.31x	1.42x	1.28x	1.17x
PEG	-	0.9x	3.41x	0.2x	-2.82x	0.6x	0.84x	0.72x
Capitalization / Revenue	2.57x	1.92x	2.02x	2.21x	1.94x	2.25x	2.09x	1.95x
EV / Revenue	2.47x	1.74x	1.92x	2.08x	1.71x	1.92x	1.68x	1.46x
EV / EBITDA	8.86x	7.1x	6.43x	5.74x	4.5x	5.03x	4.41x	3.78x
EV / EBIT	11.5x	9.09x	8.15x	6.82x	5.42x	6.09x	5.26x	4.55x
EV / FCF	-460x	12.3x	17.9x	8.26x	7.56x	8.59x	7.44x	6.36x
FCF Yield	-0.22%	8.12%	5.6%	12.1%	13.2%	11.6%	13.4%	15.7%
Dividend per Share ²	225	390	-	-	-	620.6	664.4	733
Rate of return	2.58%	4.7%	-	-	-	5.29%	5.66%	6.24%
EPS ²	751	835	860	1,307	1,271	1,432	1,561	1,709
Distribution rate	30%	46.7%	-	-	-	43.3%	42.6%	42.9%
Net sales ¹	6,30,595	8,02,755	8,05,158	8,57,545	9,28,962	9,51,724	10,23,546	10,98,192
EBITDA ¹	1,76,123	1,96,480	2,40,625	3,10,678	3,53,314	3,63,366	3,89,794	4,24,113
EBIT ¹	1,35,832	1,53,555	1,89,817	2,61,157	2,92,851	2,99,996	3,26,732	3,51,898
Net income ¹	1,39,626	1,55,581	1,58,850	2,39,244	2,32,335	2,59,474	2,86,154	3,13,070
Net Debt ¹	-59,856	-1,46,733	-80,493	-1,10,818	-2,10,608	-3,14,590	-4,21,390	-5,40,005
Reference price ²	8,725.00	8,300.00	8,750.00	10,400.00	9,865.00	11,740.00	11,740.00	11,740.00
Nbr of stocks (in thousands)	1,85,630	1,85,818	1,85,946	1,82,035	1,82,385	1,82,388	-	-
Announcement Date	02/03/22	28/02/23	29/02/24	07/04/25	27/02/26	-	-	-

¹HUF in Million²HUF

Estimates

P/E, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	36.17x	6.84x	23.62x	0.8%	4.94TCr
OTSUKA HOLDINGS CO., LTD.	18.64x	2.11x	9.98x	1.28%	3.63TCr
CIPLA LIMITED	27.33x	3.33x	17.22x	0.9%	1.19TCr
ZYDUS LIFESCIENCES LIMITED	26.27x	3.88x	15.79x	0.6%	1.15TCr
KRKA, D. D.	19.11x	3.34x	11.99x	3.48%	898.9Cr
ONO PHARMACEUTICAL CO., LTD.	16.16x	2.08x	7x	3.21%	700.4Cr
GLENMARK PHARMACEUTICALS LIMITED	33.34x	3.79x	16.13x	0.24%	646.21Cr
AJANTA PHARMA LIMITED	40.38x	7.73x	28.68x	0.98%	440.97Cr
Average	27.18x	4.14x	16.30x	1.44%	1.7TCr
Weighted average by Cap.	27.72x	4.43x	16.93x	1.2%